The Alirocumab for Stopping Atherosclerosis Progression in Saphenous Vein Grafts (ASAP-SVG) Pilot Trial
Clinical trial NCT03542110 · TERMINATED
Trial details
- NCT number
- NCT03542110
- Sponsor
- Minneapolis Heart Institute Foundation
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-04
- Primary completion
- 2020-06-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.